ABM Respiratory Care Highlights Clinician Engagement Around BiWaze Platform at ATS

According to a recent LinkedIn post from ABM Respiratory Care, the company used its presence at the ATS conference to engage with clinicians and researchers on airway clearance, clinical practice, and potential research collaboration. The post highlights specific interest in its BiWaze Cough and BiWaze Clear platforms and invites those who did not attend to schedule product demos.

The post suggests that ABM Respiratory Care is positioning its BiWaze portfolio as a differentiated solution in respiratory and airway clearance care, targeting clinical adoption and evidence generation through collaboration. Increased engagement with healthcare professionals and research partners at a major specialty meeting could support future product validation, utilization, and reimbursement prospects, with potential long-term upside for commercial traction in the respiratory care segment.